# SALIX PHARMACEUTICALS LTD

SALIX PHARMACEUTICALS LTD is a company headquartered in Raleigh, NC, United States.

## Company overview

- **Legal name:** SALIX PHARMACEUTICALS LTD
- **Former names in filing history:** SALIX HOLDINGS LTD (1997-09-25 to 1998-01-07)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Raleigh, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001009356

## About

SALIX PHARMACEUTICALS LTD is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001009356, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2015-03-02, it reported annual revenue of USD 1,133,542,000; net income of USD -414,911,000; total assets of USD 4,117,343,000 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $1.1B (USD 1,133,542,000)
- **Net income:** -$414.9M (USD -414,911,000)
- **Total assets:** $4.1B (USD 4,117,343,000)
- **Cash and equivalents:** $499.3M (USD 499,339,000)
- **Operating cash flow:** $4.2M (USD 4,150,000)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $933.8M (USD 933,838,000)
- **Net income:** $143.0M (USD 143,034,000)
- **Total assets:** $2.9B (USD 2,941,394,000)
- **Cash and equivalents:** $1.2B (USD 1,157,850,000)
- **Operating cash flow:** $415.9M (USD 415,855,000)
- **Later filings:** Revenue, Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $735.4M (USD 735,444,000)
- **Net income:** $64.2M (USD 64,246,000)
- **Total assets:** $1.9B (USD 1,874,784,000)
- **Cash and equivalents:** $751.0M (USD 751,006,000)
- **Operating cash flow:** $87.6M (USD 87,592,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $540.5M (USD 540,488,000)
- **Net income:** $87.4M (USD 87,399,000)
- **Total assets:** $1.3B (USD 1,312,969,000)
- **Cash and equivalents:** $292.8M (USD 292,814,000)
- **Operating cash flow:** $119.2M (USD 119,150,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2015-04-01 — period 2015-04-01 — 8-K
- Form 8-K — filed 2015-03-16 — period 2015-03-16 — 8-K
- Form 10-K — filed 2015-03-02 — period 2014-12-31 — 10-K
- Form 8-K — filed 2015-03-02 — period 2015-03-02 — FORM 8-K
- Form 10-K/A — filed 2015-03-02 — period 2013-12-31 — 10-K/A
- Form 8-K — filed 2015-02-27 — period 2015-02-27 — 8-K
- Form 8-K — filed 2015-02-23 — period 2015-02-19 — FORM 8-K
- Form 8-K — filed 2015-02-23 — period 2015-02-20 — FORM 8-K
- Form SC 13G — filed 2015-02-17
- Form 8-K — filed 2015-02-17 — period 2015-02-16 — FORM 8-K
- Form 8-K — filed 2015-02-13 — period 2011-12-21 — 8-K
- Form 8-K — filed 2015-02-05 — period 2015-01-30 — FORM 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/salix-pharmaceuticals-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology